Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RYHCX vs. QAAGZX: which is better?

Bottom line

RYHCX vs QAAGZX: the short answer

RYHCX (Health Care Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds.

But QAAGZX is far broader, holding 277 positions to 135 for RYHCX, so beyond the top names it adds exposure RYHCX doesn't have.

QAAGZX is cheaper at 0.86% vs 2.4% — a difference of $154 a year per $10,000 invested.

Over five years, QAAGZX returned +4.1% a year vs +4.1% for RYHCX.

Updated Nov 19, 2026

RYHCX vs QAAGZX side by side

RYHCXQAAGZX
TypeMutual fundETF
Fund familyGuggenheimT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio2.4%0.86%
Annual cost per $10k$240$86
10-yr cost on $10k (prospectus)$2,782$1,061
Max front load0%None
12b-1 fee1%0%
1-yr return+12.3%+18.1%
5-yr return (annualized)+4.1%+4.1%
10-yr return (annualized)+6.8%+9.0%
Best quarter+18.4%+23.4%
Worst quarter−14.6%−15.8%
Net assets (fund)$19.4M$751.7M
Number of holdings135277
Portfolio turnover244%65%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRYHCXQAAGZXDifference
2025+13.3%+18.1%−4.8%
2024−0.4%+1.7%−2.1%
2023+4.8%+3.0%+1.9%
2022−12.5%−12.5%0.0%
2021+18.1%+13.1%+5.0%
2020+17.7%+29.6%−11.9%
2019+21.6%+29.0%−7.3%
2018+0.5%+1.1%−0.6%
2017+22.3%+27.6%−5.3%
2016−10.3%−10.5%+0.2%

Source: Fund prospectus bar charts

Holdings overlap

17 of RYHCX's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingRYHCXQAAGZX
Eli Lilly & Company3.63%14.06%
Johnson & Johnson2.88%6.64%
Abbvie Inc2.52%5.12%
Unitedhealth Group Inc2.22%5.88%
Merck & Company Inc2.04%4.00%
Thermo Fisher Scientific Inc1.61%2.53%
Amgen Inc1.56%1.80%
Abbott Laboratories1.42%1.91%
Gilead Sciences Inc1.39%2.79%
Vertex Pharmaceuticals Inc1.34%2.26%
Cvs Health Corp1.31%0.93%
Intuitive Surgical Inc1.31%1.89%
Danaher Corp1.30%1.44%
Bristol-myers Squibb Company1.22%2.12%
Stryker Corp1.21%1.78%

Source: SEC Form N-PORT

RYHCX top 10

  1. Eli Lilly & Company — 3.63%
  2. Johnson & Johnson — 2.88%
  3. Abbvie Inc — 2.52%
  4. Unitedhealth Group Inc — 2.22%
  5. Merck & Company Inc — 2.04%
  6. Thermo Fisher Scientific Inc — 1.61%
  7. Amgen Inc — 1.56%
  8. Abbott Laboratories — 1.42%
  9. Gilead Sciences Inc — 1.39%
  10. Vertex Pharmaceuticals Inc — 1.34%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between RYHCX and QAAGZX?
RYHCX (Health Care Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds. But QAAGZX is far broader, holding 277 positions to 135 for RYHCX, so beyond the top names it adds exposure RYHCX doesn't have.
Which is cheaper, RYHCX or QAAGZX?
QAAGZX has the lower expense ratio (0.86%).
Should I own both RYHCX and QAAGZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.